{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:56:49Z","timestamp":1789084609698,"version":"build-2803163510"},"reference-count":10,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.3201\/eid3103.241675","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:58:51Z","timestamp":1740178731000},"source":"Crossref","is-referenced-by-count":10,"title":["Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019\u20132023"],"prefix":"10.3201","volume":"31","author":[{"given":"Olha","family":"Konstantynovska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Synenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Honcharenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olha","family":"Volobuieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Liadova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumitru","family":"Chesov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3103.241675-202501241530-R1","unstructured":"World Health Organization. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: The Organization; 2024."},{"key":"key-10.3201\/eid3103.241675-202501241530-R2","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva: The Organization; 2024."},{"key":"key-10.3201\/eid3103.241675-202501241530-R3","unstructured":"World Health Organization. Key updates to the treatment of drug-resistant tuberculosis: rapid communication. Geneva: The Organization; 2024."},{"key":"key-10.3201\/eid3103.241675-202501241530-R4","doi-asserted-by":"publisher","first-page":"2100621","DOI":"10.1183\/13993003.00621-2021","article-title":"Emergence of bedaquiline resistance in a high tuberculosis burden country.","volume":"59","author":"Chesov","year":"2022","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid3103.241675-202501241530-R5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5588\/ijtld.19.0508","article-title":"Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine.","volume":"24","author":"Butov","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid3103.241675-202501241530-R6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jinf.2023.06.014","article-title":"Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis.","volume":"87","author":"Pedersen","year":"2023","journal-title":"J Infect"},{"key":"key-10.3201\/eid3103.241675-202501241530-R7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1440-1843.2011.01990.x","article-title":"Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.","volume":"16","author":"Liu","year":"2011","journal-title":"Respirology"},{"key":"key-10.3201\/eid3103.241675-202501241530-R8","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1128\/AAC.01749-15","article-title":"Impact of fluoroquinolone exposure prior to tuberculosis diagnosis on clinical outcomes in immunocompromised patients.","volume":"60","author":"Lee","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3103.241675-202501241530-R9","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1016\/j.ijid.2010.11.008","article-title":"Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis.","volume":"15","author":"Chen","year":"2011","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid3103.241675-202501241530-R10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1473-3099(14)70071-4","article-title":"Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe.","volume":"14","author":"Versporten","year":"2014","journal-title":"Lancet Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:58:53Z","timestamp":1740178733000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/31\/3\/24-1675_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3103.241675","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}